Document is current
Any future updates will be listed below
-
Authors
Friedrich, Maximilian
Son, Hyeck-Soo
Lind, Jasper
Hammer, Maximilian
Chychko, Lizaveta
Yildirim, Timur Mert
Auffarth, Gerd Uwe
Augustin, Victor Aristide
-
Funding
Funding for this research was provided by:
Klaus Tschira Stiftung
Medizinische Fakultät Heidelberg der Universität Heidelberg
- License Information
-
More Information
Article History
Received: 14 September 2024
Accepted: 6 February 2025
First Online: 1 March 2025
Declarations
:
: This study was approved by the Institutional Review Board/Ethics Committee (ID: S-565/2023) at the Ruprecht-Karls University Heidelberg, Germany, and performed in accordance with the tenets of the Declaration of Helsinki. Informed consent was obtained from all participants.
: Not applicable.
: T.M. Yildirim reports lecture fees from Alcon Laboratories, Johnson & Johnson Vision and Hoya Corp. and nonfinancial support from Johnson & Johnson Vision. G.U. Auffarth reports lecture fees and research grants from Johnson & Johnson Vision, Alcon Laboratories, Carl Zeiss Meditec AG, Hoya Corp., Kowa Co., Ltd., Oculentis GmbH/Teleon, Physiol S.A., Rayner Intraocular Lenses Ltd., Oculus Optikgeräte GmbH, Ophthec BV, Santen, Sifi Medtech Srl, Acufocus Inc., Novartis, Ursapharm and Biotech; nonfinancial support from Rheacell, Contamac, Cristalens, Croma, EyeYon, Hanita, and VSY outside the submitted work. V. A. Augustin reports research grants from Kowa Co. outside the submitted work. The remaining authors have no conflicts to declare.
